Rite Aid Corp (RAD)
$13.78 1.36 (8.98%)
13:01 EST RAD Stock Quote Delayed 15 Minutes
Previous Close $15.10
Market Cap 14.70B
PE Ratio -40.53
Volume (Avg. Vol.) 3.16M
Day's Range 13.75 - 15.38
52-Week Range 0.43 - 23.88
Dividend & Yield N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
- From InvestorPlace
- From the Web
My regular readers know I never want to buck the tape, or go against the action in the market, which is why I am recommending a bullish call option on Rite Aid Corporation (NYSE:RAD).
RAD stock is trading as if the Rite Aid turnaround is a certainty, but it's anything but that, and that makes the stock quite risky.
Roku and Nvidia earnings previews, plus Centurylink, Rite Aid and Microsoft were our top stock trades for Friday.
RAD stock jumped higher off a strong Q4 earnings beat but without a viable recovery narrative. This is where the story ends.
There's an old investment saying that goes something like (forgive my paraphrasing) “credit leads equity.” What that means is that a company's corporate debt can be a tell about future price action in the stock. Rite Aid recently exchanged $600 million in notes coming due in 2023 for notes maturing in 2025. While that move will help with interest expense, at least one ratings agency doesn't see a reason to upgrade the company's flimsy credit rating.
Rite Aid is still a risky play, but the technicals finally look attractive and the fundamentals are improving for RAD stock.
Rite Aid shares have been seized with volatility, making RAD stock a toss-up play for bears and bulls alike.
By Thomas Niel
Outside of another short squeeze, it's tough to see RAD stock going higher long-term. Even after the rally, shares remain a sell.
RAD stock appears like an interesting bet considering its present market discount. However, speculators should be aware that the company’s financial health leaves much to be desired.
While markets may roar to all-time highs in 2020, these five stocks likely will miss the party and are stocks to sell in the new year.
By David Moadel
Bargains in the health-care sector like RAD stock don't come along all that often. It's time to go against the grain and pick up some shares.
RAD stock nearly tripled in the last month of 2019, but Rite Aid stock subsequently fell and looks poised for more declines.
The M&A market could bounce back in 2020, and as it does, investors should keep an eye on these seven buyout targets.
By Ian Cooper
With a heavy debt load and mounting competition, Rite Aid stock is looking like one to avoid as we begin 2020.
General Mills, Tesla, Rite Aid and Medifast were our top stock trades from Thursday. Let's look at the charts going into Friday.
Rite Aid (RAD) earnings for the U.S. pharmacy company's third quarter of fiscal 2020 have RAD stock flying high on Thursday.
These once-profitable retail stocks have reached penny-stock status due to declining sales and financials that continue to deteriorate.
These stocks to sell will likely face pain in 2020 as these equities face worsening conditions and increasing financial and market pressure.
From Market News Video
Investors in Rite Aid Corp (RAD) saw new options begin trading today, for the October 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Sunday’s Highlights at Noon: Brainstorm Cell Therapeutics (BCLI), Peabody Energy Comm (BTU), Rite Aid (RAD), Glu Mobile (GLUU), Advanced Micro Devices (AMD)
So far Sunday, February 23, NASDAQ is down -5.15% and the S&P is down -1.99%. Here are this morning’s most active stocks: Brainstorm Cell Therapeutics (BCLI – Research Report), Peabody Energy Comm (BTU – Research Report), Rite Aid (RAD – Research Report), Glu Mobile (GLUU – Research Report) and Advanced Micro Devices (AMD – Research
Saturday’s Highlights at Noon: Brainstorm Cell Therapeutics (BCLI), Peabody Energy Comm (BTU), Rite Aid (RAD), Glu Mobile (GLUU), Advanced Micro Devices (AMD)
So far Saturday, February 22, NASDAQ is down -5.15% and the S&P is down -1.99%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Brainstorm Cell Therapeutics (BCLI – Research Report), Peabody Energy Comm (BTU – Research Report), Rite Aid (RAD – Research Report), Glu Mobile (GLUU – Research
Friday’s Highlights at Noon: Mallinckrodt (MNK), Peabody Energy Comm (BTU), Rite Aid (RAD), Glu Mobile (GLUU), Brainstorm Cell Therapeutics (BCLI)
So far Friday, February 21, NASDAQ is down -1.87% and the S&P is down -1.22%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Mallinckrodt (MNK – Research Report), Peabody Energy Comm (BTU – Research Report), Rite Aid (RAD – Research Report), Glu Mobile (GLUU – Research Report) and
Navellier RatingsPowered by Portfolio Grader